Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 9, 2026 · Filed Apr 14, 2026
The CEO of Belite Bio sold $547K of Belite Bio shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$547,188
Shares × reported transaction price
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.9% | +1.4% | −5.3% |
| 30 days | −12.8% | +7.7% | −20.5% |
| 90 days | −14.5% | +7.9% | −22.4% |
| 180 days | −7.8% | +12.0% | −19.8% |
Past results only. Not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.